+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Preventing liver fibrosis by transfer of PLGA-micropheres encapsulating antifibrotic devices

Preventing liver fibrosis by transfer of PLGA-micropheres encapsulating antifibrotic devices

International Journal of Artificial Organs 26(7): 637

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 035550470

Download citation: RISBibTeXText

Related references

Partial correction of cystic fibrosis defects with PLGA nanoparticles encapsulating curcumin. Molecular Pharmaceutics 7(1): 86-93, 2010

Positively charged mucoadhesive PLGA micropheres for pulmonary delivery of rifampicin. Journal of Pharmacy & Pharmacology 55(Suppl.): S 14-S 15, 2003

Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. American Journal of Cardiology 71(3): 12a-16a, 1993

Precision-cut liver slices as a model for the early onset of liver fibrosis to test antifibrotic drugs. Toxicology and Applied Pharmacology 274(2): 328-338, 2014

Human precision-cut liver slices as a model to test antifibrotic drugs in the early onset of liver fibrosis. Toxicology in Vitro 35: 77-85, 2016

Apoptosis and liver fibrosis: antifibrotic strategies. Biomedicine and PharmacoTherapy 52(6): 259-263, 1998

Liver fibrosis: Common mechanisms and antifibrotic therapies. Clinics and Research in Hepatology and Gastroenterology 39(Suppl. 1): S51-S59, 2015

The antifibrotic effects of D-penicillamine in liver fibrosis animal. Yakhak Hoeji 40(5): 550-557, 1996

Antifibrotic effects of protocatechuic aldehyde on experimental liver fibrosis. Pharmaceutical Biology 50(4): 413-419, 2012

Antifibrotic effect of heparin on liver fibrosis model in rats. World Journal of Gastrointestinal Pharmacology and Therapeutics 3(6): 86-92, 2012

Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology 50(4): 1294-1306, 2009

Antifibrotic potential of a selective COX-2 inhibitor celecoxib on liver fibrosis in rats. Comparative Clinical Pathology 22(3): 425-430, 2013

Antifibrotic effects of green tea on in vitro and in vivo models of liver fibrosis. World Journal of Gastroenterology 15(41): 5200-5205, 2009

Antifibrotic activity of hesperidin against dimethylnitrosamine-induced liver fibrosis in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 387(6): 559-567, 2014

Improved antifibrotic effect of a combination of verapamil and silymarin in rat-induced liver fibrosis. Arab Journal of Gastroenterology 12(3): 143-149, 2011